LILIANA KIM: Open Payments
NPI 1326652900 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,536 in 76 payments from 11 companies in 2025. Trend: 2023 $1,895 · 2024 $756 · 2025 $1,536
Food & beverage: $1,536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $455 |
| Janssen Pharmaceuticals, Inc | 10 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Alkermes, Inc. | 5 | $91 |
| Collegium Pharmaceutical, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Lundbeck LLC | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
Products named: VRAYLAR, SPRAVATO, REXULTI, CAPLYTA, ARISTADA, Jornay PM, Auvelity, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
